tiprankstipranks
Trending News
More News >
Jagsonpal Pharmaceuticals Ltd. (IN:JAGSNPHARM)
:JAGSNPHARM
India Market

Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Financial Statements

Compare
2 Followers

Jagsonpal Pharmaceuticals Ltd. Financial Overview

Jagsonpal Pharmaceuticals Ltd.'s market cap is currently ₹11.30B. The company's EPS TTM is ₹1.64; its P/E ratio is 27.54; and it has a dividend yield of 1.24%. Jagsonpal Pharmaceuticals Ltd. is scheduled to report earnings on January 21, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 2.69B₹ 2.09B₹ 2.37B₹ 2.18B₹ 1.88B
Gross Profit₹ 1.72B₹ 652.59M₹ 1.44B₹ 1.28B₹ 1.07B
Operating Income₹ 435.49M₹ 214.04M₹ 343.30M₹ 245.45M₹ 187.86M
EBITDA₹ 510.71M₹ 323.46M₹ 363.96M₹ 284.53M₹ 234.72M
Net Income₹ 553.61M₹ 224.63M₹ 267.21M₹ 188.55M₹ 170.58M
Balance Sheet
Cash & Short-Term Investments₹ 1.29B₹ 1.48B₹ 1.15B₹ 472.77M₹ 618.82M
Total Assets₹ 2.78B₹ 2.17B₹ 1.95B₹ 1.68B₹ 1.64B
Total Debt₹ 92.39M₹ 89.41M₹ 60.01M₹ 52.47M₹ 67.88M
Net Debt₹ -1.19B₹ -38.19M₹ -50.52M₹ -251.35M₹ -518.44M
Total Liabilities₹ 383.10M₹ 296.76M₹ 360.56M₹ 375.99M₹ 422.73M
Stockholders' Equity₹ 2.40B₹ 1.87B₹ 1.59B₹ 1.31B₹ 1.22B
Cash Flow
Free Cash Flow₹ 549.52M₹ 349.18M₹ 463.37M₹ 51.31M₹ 277.53M
Operating Cash Flow₹ 553.00M₹ 351.66M₹ 466.54M₹ 55.98M₹ 282.22M
Investing Cash Flow₹ -451.47M₹ -245.48M₹ -576.71M₹ -257.79M₹ -22.64M
Financing Cash Flow₹ -116.98M₹ -89.11M₹ -4.57M₹ -175.52M₹ -68.28M
Currency in INR

Jagsonpal Pharmaceuticals Ltd. Earnings and Revenue History

Jagsonpal Pharmaceuticals Ltd. Debt to Assets

Jagsonpal Pharmaceuticals Ltd. Cash Flow

Jagsonpal Pharmaceuticals Ltd. Forecast EPS vs Actual EPS